Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2978 | 2605 | 25.4 | 59% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
320 | 3 | AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//MEDICATION ERRORS//AMERICAN JOURNAL OF HOSPITAL PHARMACY | 39312 |
2978 | 2 | PHARMACOVIGILANCE//ADVERSE DRUG REACTIONS//DRUG SAFETY | 2605 |
4114 | 1 | PHARMACOVIGILANCE//ADVERSE DRUG REACTIONS//DRUG SAFETY | 1844 |
22432 | 1 | SELF CONTROLLED CASE SERIES//VACCINE SAFETY//IMMUNIZAT SAFETY OFF | 381 |
28567 | 1 | CODISPENSING//RISK EVALUATION AND MITIGATION STRATEGIES//BOXED WARNINGS | 204 |
30020 | 1 | BENEFIT RISK//BENEFIT RISK ASSESSMENT//BENEFIT RISK COMMUNICATION | 176 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PHARMACOVIGILANCE | authKW | 1753107 | 15% | 38% | 399 |
2 | ADVERSE DRUG REACTIONS | authKW | 624018 | 14% | 15% | 364 |
3 | DRUG SAFETY | journal | 550691 | 12% | 15% | 313 |
4 | SPONTANEOUS REPORTING | authKW | 478230 | 3% | 61% | 67 |
5 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | journal | 375536 | 10% | 12% | 272 |
6 | SELF CONTROLLED CASE SERIES | authKW | 208809 | 1% | 64% | 28 |
7 | ADVERSE DRUG REACTION REPORTING SYSTEMS | authKW | 177207 | 2% | 34% | 44 |
8 | SPONTANEOUS REPORTING SYSTEM | authKW | 155828 | 1% | 53% | 25 |
9 | ADR REPORTING | authKW | 153140 | 1% | 93% | 14 |
10 | RISK MANAGEMENT STRATEGY | address | 143567 | 1% | 88% | 14 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 26378 | 58% | 0% | 1515 |
2 | Public, Environmental & Occupational Health | 14900 | 31% | 0% | 816 |
3 | Medical Informatics | 10412 | 8% | 0% | 206 |
4 | Toxicology | 5187 | 14% | 0% | 362 |
5 | Health Care Sciences & Services | 4811 | 10% | 0% | 249 |
6 | Mathematical & Computational Biology | 1470 | 5% | 0% | 121 |
7 | Statistics & Probability | 1325 | 6% | 0% | 156 |
8 | Medicine, General & Internal | 881 | 10% | 0% | 261 |
9 | Medicine, Research & Experimental | 403 | 6% | 0% | 151 |
10 | Health Policy & Services | 305 | 2% | 0% | 53 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RISK MANAGEMENT STRATEGY | 143567 | 1% | 88% | 14 |
2 | UPPSALA MONITORING | 131889 | 1% | 49% | 23 |
3 | PHARM PHARMACOTHER Y PHARMACEUT CARE | 88626 | 0% | 69% | 11 |
4 | IMMUNIZAT SAFETY OFF | 80145 | 1% | 18% | 38 |
5 | ABORATING INT DRUG MONITORING | 76912 | 1% | 41% | 16 |
6 | OBSERVAT MED OUTCOMES PARTNERSHIP | 60273 | 0% | 86% | 6 |
7 | LESIM | 57692 | 0% | 62% | 8 |
8 | INTEGRAT EDUC PHARM PHARMACEUT SCI | 53570 | 0% | 57% | 8 |
9 | OFF BIOSTAT EPIDEMIOL | 50213 | 1% | 16% | 27 |
10 | POST LICENSING | 42187 | 0% | 60% | 6 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DRUG SAFETY | 550691 | 12% | 15% | 313 |
2 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 375536 | 10% | 12% | 272 |
3 | DRUG INFORMATION JOURNAL | 43640 | 2% | 6% | 64 |
4 | THERAPEUTIC INNOVATION & REGULATORY SCIENCE | 35100 | 1% | 9% | 33 |
5 | THERAPIE | 31689 | 3% | 3% | 83 |
6 | ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS | 12001 | 1% | 7% | 14 |
7 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 10824 | 3% | 1% | 87 |
8 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 8734 | 3% | 1% | 73 |
9 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 5786 | 2% | 1% | 54 |
10 | STATISTICS IN BIOPHARMACEUTICAL RESEARCH | 5510 | 0% | 4% | 12 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PHARMACOVIGILANCE | 1753107 | 15% | 38% | 399 | Search PHARMACOVIGILANCE | Search PHARMACOVIGILANCE |
2 | ADVERSE DRUG REACTIONS | 624018 | 14% | 15% | 364 | Search ADVERSE+DRUG+REACTIONS | Search ADVERSE+DRUG+REACTIONS |
3 | SPONTANEOUS REPORTING | 478230 | 3% | 61% | 67 | Search SPONTANEOUS+REPORTING | Search SPONTANEOUS+REPORTING |
4 | SELF CONTROLLED CASE SERIES | 208809 | 1% | 64% | 28 | Search SELF+CONTROLLED+CASE+SERIES | Search SELF+CONTROLLED+CASE+SERIES |
5 | ADVERSE DRUG REACTION REPORTING SYSTEMS | 177207 | 2% | 34% | 44 | Search ADVERSE+DRUG+REACTION+REPORTING+SYSTEMS | Search ADVERSE+DRUG+REACTION+REPORTING+SYSTEMS |
6 | SPONTANEOUS REPORTING SYSTEM | 155828 | 1% | 53% | 25 | Search SPONTANEOUS+REPORTING+SYSTEM | Search SPONTANEOUS+REPORTING+SYSTEM |
7 | ADR REPORTING | 153140 | 1% | 93% | 14 | Search ADR+REPORTING | Search ADR+REPORTING |
8 | DRUG SAFETY | 149117 | 4% | 12% | 106 | Search DRUG+SAFETY | Search DRUG+SAFETY |
9 | MEDDRA | 135472 | 1% | 68% | 17 | Search MEDDRA | Search MEDDRA |
10 | BENEFIT RISK | 134254 | 1% | 44% | 26 | Search BENEFIT+RISK | Search BENEFIT+RISK |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | BATE, A , EVANS, SJW , (2009) QUANTITATIVE SIGNAL DETECTION USING SPONTANEOUS ADR REPORTING.PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. VOL. 18. ISSUE 6. P. 427-436 | 50 | 91% | 160 |
2 | SAKAEDA, T , TAMON, A , KADOYAMA, K , OKUNO, Y , (2013) DATA MINING OF THE PUBLIC VERSION OF THE FDA ADVERSE EVENT REPORTING SYSTEM.INTERNATIONAL JOURNAL OF MEDICAL SCIENCES. VOL. 10. ISSUE 7. P. 796-803 | 54 | 72% | 49 |
3 | WISNIEWSKI, AFZ , BATE, A , BOUSQUET, C , BRUECKNER, A , CANDORE, G , JUHLIN, K , MACIA-MARTINEZ, MA , MANLIK, K , QUARCOO, N , SEABROKE, S , ET AL (2016) GOOD SIGNAL DETECTION PRACTICES: EVIDENCE FROM IMI PROTECT.DRUG SAFETY. VOL. 39. ISSUE 6. P. 469 -490 | 48 | 92% | 0 |
4 | KOUTKIAS, VG , JAULENT, MC , (2015) COMPUTATIONAL APPROACHES FOR PHARMACOVIGILANCE SIGNAL DETECTION: TOWARD INTEGRATED AND SEMANTICALLY-ENRICHED FRAMEWORKS.DRUG SAFETY. VOL. 38. ISSUE 3. P. 219 -232 | 43 | 91% | 5 |
5 | LOPEZ-GONZALEZ, E , HERDEIRO, MT , FIGUEIRAS, A , (2009) DETERMINANTS OF UNDER-REPORTING OF ADVERSE DRUG REACTIONS A SYSTEMATIC REVIEW.DRUG SAFETY. VOL. 32. ISSUE 1. P. 19-31 | 39 | 93% | 127 |
6 | INACIO, P , CAVACO, A , AIRAKSINEN, M , (2017) THE VALUE OF PATIENT REPORTING TO THE PHARMACOVIGILANCE SYSTEM: A SYSTEMATIC REVIEW.BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 83. ISSUE 2. P. 227 -246 | 42 | 91% | 0 |
7 | GONZALEZ-GONZALEZ, C , LOPEZ-GONZALEZ, E , HERDEIRO, MT , FIGUEIRAS, A , (2013) STRATEGIES TO IMPROVE ADVERSE DRUG REACTION REPORTING: A CRITICAL AND SYSTEMATIC REVIEW.DRUG SAFETY. VOL. 36. ISSUE 5. P. 317 -328 | 42 | 84% | 17 |
8 | VARALLO, FR , GUIMARAES, SDP , ABJAUDE, SAR , MASTROIANNI, PD , (2014) CAUSES FOR THE UNDERREPORTING OF ADVERSE DRUG EVENTS BY HEALTH PROFESSIONALS: A SYSTEMATIC REVIEW.REVISTA DA ESCOLA DE ENFERMAGEM DA USP. VOL. 48. ISSUE 4. P. 739 -747 | 39 | 91% | 7 |
9 | HAUBEN, M , BATE, A , (2009) DECISION SUPPORT METHODS FOR THE DETECTION OF ADVERSE EVENTS IN POST-MARKETING DATA.DRUG DISCOVERY TODAY. VOL. 14. ISSUE 7-8. P. 343 -357 | 38 | 81% | 57 |
10 | HAZELL, L , SHAKIR, SAW , (2006) UNDER-REPORTING OF ADVERSE DRUG REACTIONS - A SYSTEMATIC REVIEW.DRUG SAFETY. VOL. 29. ISSUE 5. P. 385-396 | 31 | 76% | 398 |
Classes with closest relation at Level 2 |